Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts: A Pilot Study
| Registry | NCT07432893 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, crossover, masking: single, treatment |
| Enrollment | 736 (Actual) |
| Sponsor | Sarah Nabia (Other); collaborators: Liver Foundation, West Bengal, Endless Health |
| Conditions | Hypertension, Diabete Mellitus, Breathlessness, Fever |
| Interventions | AI-enabled clinical decision support tool (software) used by nurses, Physician consultation (Other) |
| Dates | start 2026-01-13, primary completion 2026-08-01, completion 2026-08-01, first posted 2026-02-25, last updated 2026-08-05 |
| Locations | 2 sites in India |
Related Papers Related Patents Related Grants Related Experts
All trials for Hypertension All trials for Diabete Mellitus All trials of AI-enabled clinical decision support tool (software) used by nurses All trials of Physician consultation
The goal of this clinical trial is to learn whether AI-enabled, nurse-led treatment planning can improve the quality of clinical reasoning and management compared with standard physician-led care in adult primary care patients (≥18 years) presenting with hypertension, diabetes mellitus, fever, breathlessness, or musculoskeletal pain in rural and semi-urban India.
The main questions it aims to answer are:
* Does a nurse + large language model (LLM) consultation achieve non-inferior clinical quality scores compared with a standard doctor consultation?
* Is AI-assisted nurse-led care acceptable and satisfactory to patients in primary healthcare settings? Researchers will compare nurse + LLM-led consultations with physician-led standard-of-care consultations within the same participant to see if the AI-enabled nurse model delivers comparable or improved clinical reasoning and treatment planning.
Participants will:
* Receive two sequential consultations for the same visit (one with a nurse using an AI tool and one with a physician, order randomized).
* Have both consultations audio recorded for blinded clinical quality assessment.
* Complete a brief exit survey on communication, trust, and satisfaction after the AI-assisted nurse consultation.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Nurse+Large language model clinical consultation | Experimental | Other: AI-enabled clinical decision support tool (software) used by nurses | Participants in this arm receive a nurse-led primary care consultation supported by a large language model (LLM)-based clinical decision support tool. During the consultation, a trained nurse conducts routine history taking and clinical assessment and engages in a multi-turn interaction with the LLM via a digital interface to support differential diagnosis, clinical reasoning, and evidence-based treatment and follow-up planning. The nurse may ask additional questions of the patient based on LLM prompts. The final clinical recommendations are generated collaboratively by the nurse using the LLM outputs and documented as a treatment plan. This arm evaluates whether AI-assisted nurse-led care can deliver clinical quality comparable to standard physician-led care in primary health settings. |
| Physician led clinical consultation (standard of care) | Active comparator | Other: Physician consultation | The doctor consultation represents standard-of-care clinical management that is already known and accepted to be effective for diagnosing and treating the study conditions. It is an active clinical intervention, not a placebo, sham, or no-intervention arm, and it serves as the comparator against the experimental nurse + LLM intervention. |
Sex: All, ages: 18 Years to any
Inclusion Criteria: 1. Adults aged ≥18 years 2. Presenting to participating primary care facilities in study sites 3. Meeting criteria for at least one of the following conditions or symptoms: * Hypertension: Known diagnosis * Diabetes mellitus: Known diagnosis or laboratory evidence (HbA1c ≥6.5%, fasting blood glucose ≥126 mg/dL, or post-prandial glucose ≥200 mg/dL) * Fever: Presenting as chief complaint * Breathlessness: Presenting as chief complaint, without evidence of fever * Musculoskeletal pain: Presenting as chief complaint, without evidence of fever 4. Able and willing to provide written informed consent 5. Willing to participate in two sequential consultations and complete an exit survey Exclusion Criteria: 1. Inability to provide informed consent due to cognitive impairment (e.g., dementia or intellectual disability) 2. Medical instability or condition requiring immediate emergency referral 3. Prior participation in the study during an earlier visit
| Facility | City | Country | Status |
|---|---|---|---|
| Liver Foundation | Birbhum, West Bengal | India | |
| Liver Foundation | Puruliya, West Bengal | India |